Once LABS is associated with the name of their global pharmapartner, this stock will gain much, much, much, larger investor exposure be it retail or institutional buying for high growth mutual funds, portfolios, etc.
The nice thing about institutionals, the buy orders are typically much larger that drives volumes and price.
New 52 week high...imho achievable this year.
Don't be surprised if this afternoon or tomorrow the buying volumes start to go up.